Itraconazole EP impurity A

Itraconazole EP Impurity A is a process-related byproduct derived from the synthetic pathway of itraconazole, featuring a 1H-1,2,4-triazole ring fused to a cyclopropane-substituted indole core, with a piperazine side chain bearing a methylamino group. The compound retains the fluoro-substituted benzyl moiety of the parent drug but exhibits a truncated aliphatic linker due to premature termination of the alkylation step. Its structural divergence arises from the absence of a key methylene bridge, leading to reduced conjugation and distinct chromatographic behavior. This impurity functions as an HPLC reference standard for monitoring synthetic consistency in itraconazole API batches.